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Abstract
Background: Lead-dependent tricuspid dysfunction (LDTD) is one of important complica-
tions in patients with cardiac implantable electronic devices. However, this phenomenon is 
probably underestimated because of an improper interpretation of its clinical symptoms. The 
aim of this study was to identify LDTD mechanisms and management in patients referred for 
transvenous lead extraction (TLE) due to lead-dependent complications.
Methods: Data of 940 patients undergoing TLE in a single center from 2009 to 2011 were 
assessed and 24 patients with LDTD were identifi ed. The general indications for TLE, pa-
cing system types and lead dwell time in both study groups were comparatively analyzed. The 
radiological and clinical effi cacy of TLE procedure was also assessed in both groups with pre-
cision estimation of clinical status patients with LDTD (before and after TLE). Additionally, 
mechanisms, concomitant lead-dependent complications and degree (severity) of LDTD before 
and after the procedure were evaluated. Telephone follow-up of LDTD patients was performed 
at the mean time 1.5 years after TLE/replacement procedure.
Results: The main indications for TLE in both groups were similar (apart from isolated 
LDTD in 45.83% patients from group I). Patients with LDTD had more complex pacing sy-
stems with more leads (2.04 in the LDTD group vs. 1.69 in the control group; p = 0.04). There 
were more unnecessary loops of lead in LDTD patients than in the control group (41.7% vs. 
5.24%; p = 0.001). There were no signifi cant differences in average time from implantation 
to extraction and the number of preceding procedures. Signifi cant tricuspid regurgitation 
(TR-grade III–IV) was found in 96% of LDTD patients, whereas stenosis with regurgitation 
in 4%. The 10% frequency of severe TR (not lead dependent) in the control group patients was 
observed. The main mechanism of LDTD was abnormal leafl et coaptation caused by: loop of 
the lead (42%), septal leafl et pulled toward the interventricular septum (37%) or too intensive 
lead impingement of the leafl ets (21%). LDTD patients were treated with TLE and reimplanta-
tion of the lead to the right ventricle (87.5%) or to the cardiac vein (4.2%), or surgery procedure 
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with epicardial lead placement following ineffective TLE (8.3%). The radiological and clinical 
effi cacy of TLE procedure was very high and comparable between the groups I and II (91.7% 
vs. 94.2%; p = 0.6 and 100% vs. 98.4%; p = 0.46, respectively). Repeated echocardiography 
showed reduced severity of tricuspid valve dysfunction in 62.5% of LDTD patients. The follow-
-up interview confi rmed clinical improvement in 75% of patients (further improvement after 
cardiosurgery in 2 patients was observed).
Conclusions: LDTD is a diagnostic and therapeutic challenge. The main reason for LDTD 
was abnormal leafl et coaptation caused by lead loop presence, or propping, or impingement 
the leafl ets by the lead. Probably, TLE with lead reimplantation is a safe and effective option 
in LDTD management. An alternative option is TLE with omitted tricuspid valve reimplan-
tation. Cardiac surgery with epicardial lead placement should be reserved for patients with 
ineffective previous procedures. (Cardiol J 2013; 20, 4: 402–410)
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Introduction
Tricuspid valve (TV) dysfunction is one of 
more important complications in patients with 
cardiac implantable electronic devices due to the 
endocardial lead. The frequency of this compli-
cation is underestimated and its impact on the 
clinical symptoms is attributed to other illnes-
ses. How ever, further increase in complications 
related to lead crossing the TV is expected with 
the increasing number of implanted pacemakers 
(PM), cardioverter-defi brillators (ICD) and cardiac 
resynchronization therapy devices [1]. The most 
important problem is a lack of criteria for iden-
tifying lead-dependent TV dysfunction. Available 
evidence shows diagnostic difficulties related to 
valve visualization using standard 2D echocar-
diography [2]. The hemodynamic significance of 
TV disorders, especially tricuspid regurgitation 
(TR) is difficult to assess due to high prevalence 
of this abnormality in general population, mainly 
in the elderly, as well as the need for proper eva-
luation of TR mechanism by echocardiography. 
Another important aspect is the management of 
patients with known severe TV dysfunction as 
a complication of permanent pacing, especially in 
the presence of other abnormalities.
The purpose of the present study was to ana-
lyze retrospectively the frequency of signifi cant 
(grade III/IV) TR or stenosis (taking into account 
the pathomechanisms and predisposing factors) 
due to the presence of endocardial leads in the 
population of patients referred for lead removal for 
various reasons, as well as to analyze management 
and outcomes in these patients.
Methods
We analyzed data from 940 patients undergo-
ing transvenous lead extraction (TLE) for various 
reasons in the Reference Center from 2009 to 
2011. Based on medical data the patients were 
divided into two groups: group I consisting of 24 
(2.6%) subjects with lead-dependent tricuspid 
dysfunction (LDTD) and group II consisting of the 
remaining 916 patients serving as a control group. 
The comparative analysis of indications for TLE 
in the study group was conducted with precision 
assessment of primary reasons to refer for TLE in 
LDTD population.
Patients were assigned to group I if they 
had LDTD documented by transthoracic echo-
cardiography and/or transesophageal echocar-
diography. Echocardiograms were obtained by an 
experienced echocardiographer before and after 
TLE using an IE 33 Philips device. Patients with 
TR but not evidently connected to lead presen-
ce were not included in this group of patients. 
Echocardiogra phy was repeated in all patients in 
3–5 days after the procedure. LDTD was defi ned 
as moderate or severe TR or tricuspid stenosis 
(TS) due to the presence of endocardial leads in 
the right heart chambers. The primary criterion 
for eligibility was visualization of lead-dependent 
mechanisms of tricuspid dysfunction according to 
one of the possible reasons of leafl ets coaptation 
disorders: 1. presence of the loop of lead, irrita-
ting the TV; 2. propping the leafl et by the lead; 
3. impingement of the leafl et by the lead. Severity 
of TR was assessed as the extent of the regurgitant 
jet into the right atrium using Doppler color fl ow 
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imaging. Moderate TR (grade III) was defi ned as 
a regurgitant jet extending to less than a half of 
the right atrium, whereas severe TR (grade IV) as 
a jet extending to more than a half of the length of 
the right atrium. Pulsed wave and continuous wave 
Doppler ultrasound was performed to measure the 
spectrum of the regurgitant jet and to estimate the 
pulmonary artery systolic pressure (PASP). Lead-
-dependent TS was diagnosed based on measure-
ments of tricuspid fl ow velocities with maximal and 
mean transvalvular gradients. TS was defi ned as an 
increase in transvalvular fl ow velocity > 1 m/s and 
mean transvalvular pressure gradient > 5 mm Hg. 
Patients with severe concomitant mitral valve 
dysfunction were excluded from the LDTD group.
Group II consisted of the remaining 916 pa-
tients who in 2009–2011 were undergoing TLE 
procedures. The assessment of TR frequency (not 
related to the lead presence) in those patients was 
conducted.
In order to identify factors that affect the de-
velopment of LDTD we carried out a comparative 
analysis of the number, type and dwell time of the 
leads, as well as the type of pacing systems. We 
also analyzed the presence of complications rela-
ted to TLE and radiological and clinical effi cacy 
of the procedure in both groups. Additionally, in 
group I we evaluated the type and mechanisms of 
LDTD, echocardiographic parameters confi rming 
the hemodynamic signifi cance of tricuspid dys-
function, left ventricular ejection fraction (LVEF), 
clinical consequences of LDTD, treatment type, 
and severity of tricuspid dysfunction in 3–5 days 
after lead extraction. A telephone follow-up of 
the LDTD patients was performed to assess the 
clinical outcome and survival at mean time of 
1.5 years after the procedure (local ethic committee 
approval number 2/2012).
Statistical analysis
Continuous variables were expressed as 
mean ± standard deviation. Student’s t-test was 
used to test for the significance of differences 
between the means. Qualitative variables were 
compared using the c2 test. A P-value of £ 0.05 
(two-sided) was considered statistically signifi cant.
Results
Demographic factors
The mean age of LDTD patients was 66.8 ± 
± 16.0 years and did not differ from that of the re-
maining patients (65.04 ± 16.1 years) undergoing 
TLE for other complications of permanent pacing. 
In both groups TLE was performed more frequ-
ently in men with a trend of frequent prevalence 
of LDTD in women as compared with the control 
group (Fig. 1).
Indications for TLE
The most frequent indication for TLE in both 
groups of patients was lead’s dysfunction or ne-
cessity to remove unnecessary leads. The second 
cause was infectious complications. There were 
no signifi cant differences in the kind of indications 
for TLE between the groups (apart from LDTD 
presence in group I) (Table 1).
Patients in group I, apart from LDTD, had 
other complications of pacing therapy. Most frequ-
ently, LDTD was concomitant with the presence of 
loops of leads (10 patients; 41.7%) and infectious 
complications (7 patients; 29.2%). Additionally, 
2 (8.3%) patients were found to have lead fractures 
and another 2 (8.3%) patients had lead-related dry 
right ventricular (RV) wall perforation up to the 
Figure 1. Demographic data; LDTD — lead-dependent 
tricuspid dysfunction.
Table 1. Indications for transvenous lead extraction.
LDTD Control group P
Dysfunction of the lead/
/unnecessary lead 
70.83% (including isolated 
LDTD in 45.73%)
58.91% 0.23
Infectious complications Pocket infection 8.33% 23.06% 0.1
LDIE 20.83% 18.03% 0.7
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epicardial fat. In 3 (12.5%) cases TLE was perfor-
med primarily in order to remove redundant leads. 
The complex coexistence of above mentioned 
complications in LDTD individuals was observed. 
Altogether, complications of permanent pacing 
concomitant with LDTD were found in 13 (54%) 
patients, in 11 (46%) subjects the sole reason for 
referral for lead extraction was LDTD.
Pacing systems
LDTD presence did not show simply a rela-
tion to complexity of pacing system. Comparative 
analysis of type of the leads indicated a higher 
number of RV leads in patients from group I but 
LDTD was unexpectedly frequently observed in 
patients having atrial leads. It seems to be caused 
by too long loops of atrial leads or by presence of 
abandoned leads (Table 2, Fig. 2).
In relation to the complexity of pacing sy-
stems (including abandoned leads) the number 
of extracted leads in LDTD patients was statisti-
cally higher than in the remaining ones (Fig. 3). 
In LDTD patients the mean time from lead pla-
cement to lead extraction was similar to that in 
the control group. There were no significant dif-
ferences in the number of procedures preceding 
TLE, either. In LDTD patients a large loop of 
lead, crossing the TV (most often related to the 
dysfunction of lead fixing strip or lead fracture) 
was a significantly more frequent abnormality, 
probably affecting TV function. The most frequent 
presence of the atrial than ventricular lead loops 
was observed in 7 (29%) LDTD patients. There 
was also a slight trend towards frequent numbers 
of abandoned leads in these patients (Table 3).
The analysis of course of TLE and periproce-
dural events showed a statistically higher preva-
lence of technical complications in LDTD patients 
(33.3% vs. 17.1%; p = 0.04). Most frequently 
a breakdown (12.5%) or fragmentation of the lead 
(12.5%) were observed. In 8.3% of LDTD patients 
the advanced fi brosis reaction to lead was affi rmed 
by failed TLE effort (Figs. 4, 5). The total number 
of major and minor complications related to TLE 
(defi ned according to HRS Expert Consensus) and 
the radiological success were comparably frequent in 
both groups with a trend towards higher prevalence of 
these complications in the control group (Fig. 5) [3].
The clinical effi cacy of TLE procedure was 
very high and comparable between the groups 
(100% vs. 98.4%; p = 0.46).
Table 2. Comparative analysis of the types of leads.
Types of leads LDTD (total 58) Control group (total 1,648) P
Atrial 24 (41.4%) 718 (43.6%) 0.71
Right ventricular 30 (51.7%) 593 (36.0%) 0.02
Left ventricular 1 (1.7%) 79 (4.8%) 0.25
Defibrillator 3 (5.2%) 258 (15.7%) 0.04
LDTD — lead-dependent tricuspid dysfunction
Figure 2. Comparison of pacemaker complexities; 
ICD — implantable cardioverter-defibrillator; LDTD — lead-
-dependent tricuspid dysfunction.
Figure 3. Comparison of numbers of lead removals; 
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Assessment of tricuspid valve 
dysfunction in group I
LDTD patients most frequently had severe 
TR, i.e. 20 (83%) patients. Four (16.7%) patients 
had TS with signifi cant TR. The basic mechanism 
of LDTD was abnormal leafl et coaptation. In 10 
(41.7%) patients this phenomenon was related 
to the presence of loops of leads in the tricuspid 
orifi ce, directly irritating the leafl ets and causing 
their incomplete coaptation during ventricular 
systole. In 3 (12.5%) patients the lead loops were 
ingrown into the valve leafl ets, which in 1 (4%) case 
did not allow for transvenous lead removal due to 
high risk of accidental leafl et damage. The second 
cause of abnormal coaptation was the lead propping 
on the leafl et — this mechanism was detected in 
9 (37.5%) patients. In another 5 (20.8%) patients 
malcoaptation was a result of impingement on the 
leafl ets by the lead causing valve leakage (Fig. 6).
In all 4 (16.7%) patients with TS coexisting 
with severe TR, valve dysfunction resulted from 
the lead loop ingrown into the leafl et with second-
ary valve stenosis and leakage.
The qualitative analysis of TR showed grade III 
and IV TR in 18 (75%) and 6 (25%) patients, re-
spectively. The mean PASP was 42.1 ± 12.8 mm Hg 
with the PASP value not exceeding 40 mm Hg in 
12 (50%) patients (Fig. 7).
The mean tricuspid fl ow velocity and gradient in 
patients with lead-dependent TS was 1.63 ± 0.25 m/s 
and 6 ± 0.82 mm Hg.
The mean LVEF was 44.8% ± 13.7 and severe 
systolic dysfunction (LVEF < 30%) was detected 
in 5 (20.8%) patients with LDTD (Fig. 8).
In 18 (75%) patients severe RV decompensa-
tion (NYHA class III/IV) was detected.
Table 3. Comparative analysis of mean dwell time and the commonest complications of pacing 
treatment in both study groups.
LDTD (n = 24) Control group (n = 916) P
Mean lead dwell time before TLE [months] 91.0 ± 46.2 77.8 ± 57.8 0.27
Number of procedures before TLE 2.00 ± 1.53 1.92 ± 1.22 0.75
Unnecessary loops of lead in the tricuspid valve 10 (41.7%) 48 (5.24%) 0.0001
Atrial lead loops 7 (29.2%) 24 (2.62%) 0.0001
Ventricular lead loops 3 (12.5%) 24 (2.62%) 0.006
Number of abandoned leads 0.38 ± 0.71 0.21 ± 0.54 0.13
LDTD — lead-dependent tricuspid dysfunction; TLE — transvenous lead extraction
Figure 4. Transvenous lead extraction complications.
Figure 5. Comparative analysis of periprocedural com-
plications and radiological efficacy of transvenous lead 
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Type and effi cacy of LDTD management
In 21 (87.5%) patients TLE was performed 
with reimplantation of a RV lead, in 1 (4.2%) pa-
tient a LV lead was placed in the coronary sinus 
branches. Because of the TLE failure 2 (8.3%) pa-
tients were referred for surgical procedure of lead 
removal and positioning of epicardial leads directly 
on the myocardium of the LV. The procedures were 
withdrawn due to complications in 2 patients: in 
1 patient occurred a following breakdown of ven-
tricular lead, and in the next one because of strong 
adhesion of atrial lead loop with the TV leafl et.
Repeat echocardiograms showed improved 
tricuspid function in 15 (62.5%) patients, including 
12 (50%) subjects in whom TLE with lead reim-
plantation diminished TR to grade II and in 3 out 
of 4 patients with TS it resulted in a reduction of 
transvalvular gradient (by 3/1.5 mm Hg on average). 
In the remaining 9 (37.5%) patients echocardiography 
did not show improvement, i.e. diminished severity 
of TV dysfunction, but in 2 patients further clinical 
improvement after cardiosurgery was observed.
Telephone follow-up (in the mean time 1.5 year 
after TLE) of patients with LDTD demonstrated 
marked clinical improvement in 18 (75%) patients. 
In most instances patients reported improved 
exercise tolerance and reduced peripheral edema 
or no edema at all. One patient selected for heart 
transplantation showed a spectacular improvement 
after lead reimplantation propped on the septal 
tricuspid leafl et, expressed as a 10-fold increase 
in 6-min walk distance, a signifi cant increase in 
ergospirometric parameters and reduced edema 
with body mass reduction by 18 kg. The patient 
remains under careful observation with heart 
transplantation being postponed.
Within a year after TLE 2 patients underwent 
additional procedures to improve TV function: one 
subject with signifi cant TS was submitted to percuta-
neous tricuspid valvuloplasty, and the other one with 
severe TR received a mechanical TV.
Long-term mortality was 4.1%: one death due 
to severe cardiac decompensation within a year 
after the procedure.
Discussion
LDTD has been rarely discussed in the li-
terature, which is an indirect refl ection of lower 
interest in the pathology and its treatment, com-
pared to mitral valve anomalies. In clinical pra-
ctice, however, there is an increasing number of 
patients with severe cardiac decompensation after 
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impairment. The major issue is the visualization 
of the LDTD mechanism and identifi cation of the 
direct relationship between LDTD and heart failure 
worsening that concerns also patients with LV da-
mage. As it was already mentioned, the frequency 
of TV dysfunction in patients after permanent 
PM implantation has been rarely estimated. Furt-
hermore, confl icting results have been obtained. 
Echocardiography in a group of 248 patients before 
and after PM and ICD implantation revealed that 
the severity of TR was signifi cantly increased in 
24.2% of patients after the procedure with the de-
velopment of severe TR in 3.9% of patients. This 
phenomenon was more pronounced in patients with 
an ICD than a PM (32.4% vs. 20.1%; p < 0.5) [4]. 
In another study, patients with a PM/ICD did not 
show any signifi cant increase in the prevalence 
and severity of TR; mild TR developed in 16% of 
patients after implantation, TR deteriorated from 
mild to moderate in 10% cases, there was no de-
terioration from moderate to severe TR. However, 
the investigators recommended longer patient mo-
nitoring in further studies [5]. Another long-term 
study in children with congenital heart defects 
confi rmed a slight but signifi cant deterioration of 
TR after PM implantation [6]. Reports of TS in pa-
tients with PMs are extremely rare. In most cases 
lead-dependent TS resulted from restricted leafl et 
mobility or perforation due to fi brous adhesion of 
PM lead [7, 8].
The present study was an attempt to evalu-
ate the effect of PM-related factors on the deve-
lopment of LDTD. The complication tended to 
occur more frequently in women and in subjects 
with a larger number of implanted leads. More than 
50% of LDTD patients were also found to have 
concomitant complications of PM therapy (unne-
cessary loops of leads, infectious complications, 
lead dysfunction and their mechanical damage and 
perforations).
Direct causes of valve dysfunction were also 
carefully analyzed. Mechanisms of LDTD ran-
ged from abnormal coaptation as a result of lead 
impingement on the leafl ets or lead adhesion to 
the leafl et (most frequently septal and posterior 
leafl ets) or tendinous cords with progressive leafl et 
destruction, pulling the septal leafl et toward the 
interventricular septum, to functional TR due to 
RV asynchrony (altered propagation direction as 
a result of pacing) [9, 10]. The analysis of LDTD 
mechanisms in a group of 41 patients operated 
on for severe TR showed that the most common 
cause of valvular damage was mechanical injury 
to the leafl ets by the striking lead (16 patients) 
and lead adhesion to the leafl et (14 patients). In 
the fi rst case “the spinning electrode” resembled 
a cone with the TV as its basis and a tip of the elec-
trode as its apex. In 7 patients leafl et perforation 
was found, whereas in 4 patients the leafl et was 
wrapped around the lead [10]. The present study, 
apart from the above mentioned mechanisms, do-
cumented also a signifi cant relationship between 
the development of LDTD and the existence of lead 
loops crossing TV, probably strongly irritating the 
tricuspid leafl ets, which leads to malcoaptation. 
This complication is becoming visible especially in 
patients undergoing PM implantation at a younger 
age and with a longer lead created for future growth 
[11]. Another cause for the lead loops development 
is failure of the lead affi xing. The visualization of 
the lead loops is relatively easy — a circle is visible 
in RTG and echocardiography. In the present mate-
rial in 10 LDTD cases lead loops were found with 
advantage of atrial lead (7 cases). In these patients 
the problem of LDTD development was evidently 
connected with irritating TV by the lead loops.
Another important clinical fi nding in LDTD pa-
tients was severe cardiac decompensation, found in 
75% of them, coexisting with a relatively high mean 
LVEF (44.8%) and a relatively low PASP (42.1%). 
This fact appears to confi rm lead-dependent cause 
of tricuspid dysfunction resulting in an increase 
in central venous pressure through increasing RV 
preload. Higher RV end-diastolic volume causes 
an increase in right atrial pressure which in turn 
decreases venous return and cardiac output [12]. 
Prior to TLE all patients underwent venography 
which revealed contrast-enhanced blood back fl ow 
from the innominate vein and superior vena cava 
to the jugular veins to the rhythm of the heart. As 
the present study was based on echocardiography 
the phenomenon was not explored any further.
An extremely important aspect is the best 
choice of treatment in patients with LDTD. There 
is a considerable amount of controversy surroun-
ding the therapy. The basic approach appears to be 
the lead removal as the factor that causes TR. Our 
current state of knowledge allows to repair valves 
only during open-heart surgery. Currently available 
guidelines do not recommend lead extraction in 
patients with LDTD, probably for fear of potential 
aggravation of valve dysfunction in the case of 
lead adherence to the leafl et. Paradoxically, one of 
the complications of TLE is TR due to rupture of 
tendinous cords. TR as a complication after lead ex-
traction is very rare — as shows available evidence 
— despite a larger number of technical problems 
among patients with LDTD (33.3% vs. 17.1% in 
www.cardiologyjournal.org 409
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the controls; p = 0.04). The radiological success 
and the number of major and minor complications 
related to TLE were comparable in both groups. 
The present study shows that lead extraction with 
its reimplantation in the RV is suffi cient to produce 
long-term clinical improvement in 75% of patients, 
with a dramatic improvement in objective cardiova-
scular parameters in some of those patients. This 
is the result of changing the site of leads crossing 
the TV, frequently unblocking the leaflets and 
improving coaptation. There are single reports in 
the literature on the effi cacy of such an approach 
[13]. An alternative option is lead reimplantation, 
omitting the TV, i.e. LV pacing. In the present study 
this treatment option was used in 1 patient achie-
ving a positive outcome. LV pacing via the cardiac 
vein was attempted in patients after prosthetic 
TV implantation, which appeared effective; similar 
results were obtained in patients with defi brillator 
leads [14, 15]. Positive effects of more synchronous 
ventricular pacing without crossing the TV may 
also be achieved through atrioventricular pacing 
as animal studies promisingly show [16].
In case there is no improvement after TLE, 
TV repair is recommended. The commonest and 
the most sparing surgical option is tricuspid an-
nuloplasty. Annuloplasty may be combined with 
implantation of epicardial leads instead of those 
crossing the TV. Only epicardial ICD leads fail 
to produce expected results. They are left in the 
repaired TV. Because of technical problems during 
TLE in the present study this therapeutic option 
was used in 2 patients. In case of TS percutaneous 
annuloplasty is possible; this approach was used in 
1 patient about a year after TLE.
If native valves cannot be saved and it is ne-
cessary to correct a dysfunction, a prosthetic TV 
is implanted. An optimal option is simultaneous 
explantation of the lead and its replacement for 
the epicardial one, but repositioning of the lead in 
the cleft between septal and inferior leafl et is also 
performed. In one report this approach appeared 
to be effective as there were no symptoms of RV 
decompensation at 1 year follow-up [17]. How-
ever, implantation of a prosthetic TV is associated 
with high risk of periprocedural death (7–40%) 
and high (30–50%) 10-year mortality. Leaving the 
lead in situ predisposes to LDTD recurrence, and 
positioning the lead in the cleft between prosthetic 
sutures makes it impossible to perform any per-
cutaneous intervention in case of future problems 
with the lead or development of infection [18–20]. 
In the present study 1 patient necessitated implan-
tation of a prosthetic TV; during the operation the 
pacing system was explanted and replaced for the 
epicardial one.
Limitations of the study
The main limitation of the present study is its 
retrospective character. A more accurate analysis 
would be necessary to compare the degree of TV 
dysfunction in both groups. Currently, only quali-
tative evaluation of the degree of TR in group I and 
similar data regarding mitral valve are available. 
Undoubtedly, appropriate documentation of LDTD 
requires further prospective studies using new 
echocardiographic techniques.
Conclusions
1.  LDTD is a diagnostic and therapeutic challenge.
2.  Probably, TLE procedure with lead reimplan-
tation is a safe and effective option in LDTD 
management.
3.  Change of the lead route through the TV cau-
ses improvement of the leafl ets’ coaptation 
with signifi cant clinical status improvement.
4.  An alternative option is TLE with omitted TV 
reimplantation/repair.
5.  Cardiac surgery with epicardial lead placement 
should be reserved for patients with ineffecti-
ve previous procedures.
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